Wei Dong Wang

Net worth: 43 M $ as of 2024-03-30

65 year

Health Technology

Consumer Services

Profile

Founder of RemeGen Co., Ltd. and Yantai Rongchang Pharmaceutical Co. Ltd., Weidong Wang presently occupies the position of Chairman at Yantai Rongchang Pharmaceutical Co. Ltd. and Chairman at RemeGen Co., Ltd. He received an undergraduate degree from Harbin University of Commerce.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
REMEGEN CO. LTD. CLASS A 2.57%	2022-12-27	4,111,338 ( 2.57% )	31 M $	2024-03-30
REMEGEN CO. LTD. CLASS H 1.89%	2023-09-30	3,584,541 ( 1.89% )	12 M $	2024-03-30

Wei Dong Wang active positions

Companies	Position	Start
REMEGEN CO., LTD.	Founder	2008-07-03
Yantai Rongchang Pharmaceutical Co. Ltd.	Founder	1993-02-28
MabPlex International Co., Ltd. MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China.	Director/Board Member	2013-06-24

All active positions of Wei Dong Wang

Training of Wei Dong Wang

Harbin University of Commerce

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wei Dong Wang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
REMEGEN CO., LTD.	Health Technology

Private companies	2
MabPlex International Co., Ltd. MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China.	Health Technology
Yantai Rongchang Pharmaceutical Co. Ltd.